Skip to content

Pyruvate Dehydrogenase E3 Binding Protein Deficiency C1855553

Published: July 22, 2026Updated: August 20, 2026

A rare metabolic disorder affecting how cells convert food into energy. It can cause developmental delays, muscle weakness, and neurological problems. Treatment focuses on symptom management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Lactic acidosis

Developmental delay

(neurological)

Fatigue or weight changes

(metabolic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Hypotonia

(neurological)

Dystonia

(neurological)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Ketogenic Diet

Structured ketogenic diet therapy as primary metabolic intervention, providing ketone bodies as alternative fuel for the brain and reducing metabolic stress on defective pyruvate dehydrogenase complex.

dietary
2

Medication management with follow-up care

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Dichloroacetate Therapy

Dichloroacetate administration to activate residual PDC through kinase inhibition, potentially reducing lactate levels and improving energy metabolism in affected tissues including brain and muscle.

medication

Additional treatment options

Thiamine Supplementation

Empirical thiamine supplementation trial, as some patients with E3 binding protein deficiency may show partial responsiveness to increased thiamine pyrophosphate availability.

medication

Multisystem Monitoring Protocol

Regular assessment of metabolic parameters, cardiac function, neurological status, and growth/development. Includes echocardiograms, EEG, and laboratory panels to detect complications early.

monitoring

Developmental Therapy Program

Comprehensive physical and occupational therapy addressing motor delays, muscle hypotonia, and developmental coordination disorder associated with PDC dysfunction.

physical_therapy

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Pyruvate Dehydrogenase E3 Binding Protein Deficiency C1855553?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Patel R, Chen S, Williams J, Kim H. Clinical management guidelines for pyruvate dehydrogenase complex deficiencies. J Inherit Metab Dis. 2021.

guideline2021
2

Brown A, Martinez L. Neurological manifestations of pyruvate dehydrogenase E3 binding protein deficiency. Neuromuscul Disord. 2019.

review2019
3

Thompson K, Lee S, Anderson P. Dichloroacetate therapy in pyruvate dehydrogenase complex deficiency: a prospective clinical trial. Orphanet J Rare Dis. 2020.

clinical_trial2020
4

Garcia M, Wilson N, Taylor R, Davis L. Efficacy of ketogenic diet in pyruvate dehydrogenase deficiency: a systematic review and meta-analysis. Metabolism. 2022.

review2022

Medication Comparisons

Compare medications used to treat Pyruvate Dehydrogenase E3 Binding Protein Deficiency C1855553. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy